|
Volumn 31, Issue 1-2, 1999, Pages 615-616
|
Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ALLOGRAFT;
ARTERY THROMBOSIS;
CONFERENCE PAPER;
CYTOMEGALOVIRUS INFECTION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE HEMORRHAGE;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT INDICATION;
ACTUARIAL ANALYSIS;
ANTILYMPHOCYTE SERUM;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MUROMONAB-CD3;
MYCOPHENOLIC ACID;
PANCREAS TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
SURVIVAL ANALYSIS;
TACROLIMUS;
TIME FACTORS;
|
EID: 0033025258
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)01581-4 Document Type: Conference Paper |
Times cited : (5)
|
References (3)
|